Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
Titel:
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
Auteur:
Weisman, Michael H. Moreland, Larry W. Furst, Daniel E. Weinblatt, Michael E. Keystone, Edward C. Paulus, Harold E. Teoh, Leah S. Velagapudi, Raja B. Noertersheuser, Peter A. Granneman, G.Richard Fischkoff, Steven A. Chartash, Elliot K.